Fillers, biostimulators, threads and permanent injectable materials can change the tissues encountered during facelift surgery. They do not automatically prevent an operation, but concealing them can compromise diagnosis, surgical planning and recovery. The safest approach is a complete treatment history and, when indicated, dermatologic ultrasound.
Which previous treatments should be reported?
| Previous treatment | Why it matters | Possible planning step |
|---|---|---|
| Hyaluronic acid filler | May persist, migrate or contribute to edema | Clinical examination, ultrasound and selective dissolution when justified |
| Biostimulator | May produce fibrosis or nodules | Identify product, dates, planes and inflammatory history |
| Threads | Can alter tissue planes and create adhesions | Map location when possible and adapt dissection |
| PMMA or liquid silicone | Permanent materials can trigger chronic inflammation | Avoid indiscriminate manipulation; evaluate activity and extent |
| Energy-based procedures | May affect skin quality or create subcutaneous fibrosis | Review device, intensity and timing |
Why examination alone may not be enough
Patients may not remember the product name, and injectable material can remain for years. Palpation cannot always distinguish filler, fibrosis, edema and native fat. Dermatologic ultrasound may help locate material, identify its approximate plane and reveal fluid collections or nodules. It improves planning but does not identify every product with certainty.
Should filler always be dissolved first?
No. Hyaluronidase acts on hyaluronic acid, not biostimulators, fat, PMMA or silicone. Even with hyaluronic acid, the response can be incomplete and may require more than one session. Dissolution should have a clinical reason—such as persistent edema, distortion or material in a relevant surgical plane—not be used as a universal pre-facelift rule.
How previous injectables can affect surgery
Prior treatments may increase swelling, obscure anatomy or change the way tissues move. They can also influence whether the patient needs lifting, volume correction, removal of excess skin or no surgery at all. Deep Plane is not automatically the answer to fibrosis or excessive filling; additional dissection may add risk without correcting the primary problem.
Practical checklist before consultation
- List the product, date, volume and treated area whenever known.
- Request records from previous clinics.
- Report delayed swelling, nodules, infections or previous hyaluronidase.
- Avoid new injectables while surgical planning is underway.
- Do not accept promises that every product can be completely removed.
International patients may complete part of the history remotely, but the final plan depends on in-person assessment in Brazil. Belvivere coordinates hospital care through its surgical structure and logistics through the international concierge. For a broader overview, read facial injectables before surgery. The goal is not to judge previous choices, but to make the next decision with better anatomical information.
